Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
F., Ganmaa, D., Bergman, P., Bischoff-Ferrari, H
Long-term effects on follicle cycling (anagen, catagen, telogen transitions) were not assessed
Factors Affecting Peptide Stability Once reconstituted, peptides become more susceptible to degradation
People often get B12 shots as a proactive part of their wellness routine to support energy, mood, and overall health, not just to correct a deficiency
Individual results may vary and no specific outcomes are guaranteed